Peter J.P. Croucher

2.4k total citations · 2 hit papers
9 papers, 1.5k citations indexed

About

Peter J.P. Croucher is a scholar working on Hematology, Genetics and Surgery. According to data from OpenAlex, Peter J.P. Croucher has authored 9 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Hematology, 4 papers in Genetics and 3 papers in Surgery. Recurrent topics in Peter J.P. Croucher's work include Acute Myeloid Leukemia Research (4 papers), Inflammatory Bowel Disease (4 papers) and Cancer Genomics and Diagnostics (3 papers). Peter J.P. Croucher is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), Inflammatory Bowel Disease (4 papers) and Cancer Genomics and Diagnostics (3 papers). Peter J.P. Croucher collaborates with scholars based in Germany, United States and United Kingdom. Peter J.P. Croucher's co-authors include Stefan Schreiber, Jochen Hampe, Andrew Cuthbert, Christopher G. Mathew, Silvia Mascheretti, Muddassar M. Mirza, Kathy King, Alastair Forbes, Sheila Fisher and Cathryn M. Lewis and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Blood.

In The Last Decade

Peter J.P. Croucher

9 papers receiving 1.5k citations

Hit Papers

Association between insertion mutation in NOD2 gene and C... 2001 2026 2009 2017 2001 2002 250 500 750

Peers

Peter J.P. Croucher
Stephen Bridger United Kingdom
Muddassar M. Mirza United Kingdom
Oliver Brain United Kingdom
R R de Vries Netherlands
Peter J.P. Croucher
Citations per year, relative to Peter J.P. Croucher Peter J.P. Croucher (= 1×) peers Ulrich R. Foelsch

Countries citing papers authored by Peter J.P. Croucher

Since Specialization
Citations

This map shows the geographic impact of Peter J.P. Croucher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter J.P. Croucher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter J.P. Croucher more than expected).

Fields of papers citing papers by Peter J.P. Croucher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter J.P. Croucher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter J.P. Croucher. The network helps show where Peter J.P. Croucher may publish in the future.

Co-authorship network of co-authors of Peter J.P. Croucher

This figure shows the co-authorship network connecting the top 25 collaborators of Peter J.P. Croucher. A scholar is included among the top collaborators of Peter J.P. Croucher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter J.P. Croucher. Peter J.P. Croucher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Croucher, Peter J.P., Maya Ridinger, Pamela S. Becker, et al.. (2023). Spliceosome mutations are associated with clinical response in a phase 1b/2 study of the PLK1 inhibitor onvansertib in combination with decitabine in relapsed or refractory acute myeloid leukemia. Annals of Hematology. 102(11). 3049–3059. 6 indexed citations
2.
Zeidan, Amer M., Maya Ridinger, Peter J.P. Croucher, et al.. (2021). Predictive Biomarkers of Response to the Polo-like Kinase 1 (PLK1) Inhibitor, Onvansertib, in Combination with Decitabine in Relapsed or Refractory Acute Myeloid Leukemia (R/R AML). Blood. 138(Supplement 1). 3431–3431. 1 indexed citations
5.
Valentonyte, Ruta, Jochen Hampe, Peter J.P. Croucher, et al.. (2005). Study of C-C Chemokine Receptor 2 Alleles in Sarcoidosis, with Emphasis on Family-based Analysis. American Journal of Respiratory and Critical Care Medicine. 171(10). 1136–1141. 37 indexed citations
6.
Cuthbert, Andrew, Sheila Fisher, Muddassar M. Mirza, et al.. (2002). The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology. 122(4). 867–874. 523 indexed citations breakdown →
7.
Tümer, Zeynep, Peter J.P. Croucher, Lars Riff Jensen, et al.. (2002). Genomic structure, chromosome mapping and expression analysis of the human AVIL gene, and its exclusion as a candidate for locus for inflammatory bowel disease at 12q13–14 (IBD2). Gene. 288(1-2). 179–185. 15 indexed citations
8.
Hampe, Jochen, H Frenzel, Muddassar M. Mirza, et al.. (2001). Evidence for a NOD2 -independent susceptibility locus for inflammatory bowel disease on chromosome 16p. Proceedings of the National Academy of Sciences. 99(1). 321–326. 82 indexed citations
9.
Hampe, Jochen, Andrew Cuthbert, Peter J.P. Croucher, et al.. (2001). Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. The Lancet. 357(9272). 1925–1928. 837 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026